Summary: <p>This week, research updates about COVID-19: the largest trial to date of hydroxychloroquine (<a href="https://doi.org/10.1101/2020.04.10.20060558"><u><strong>https://doi.org/10.1101/2020.04.10.20060558</strong></u></a>), the first serosurvey results (<a href="https://doi.org/10.1101/2020.04.14.20062463"><u><strong>https://doi.org/10.1101/2020.04.14.20062463</strong></u></a>), doing telehealth (<a href="http://www.bmj.com/content/368/bmj.m1182"><u><strong>www.bmj.com/content/368/bmj.m1182</strong></u></a><u><strong>)</strong></u>, masks (<a href="https://doi.org/10.17226/25776"><u><strong>https://doi.org/10.17226/25776</strong></u></a><u><strong>)</strong></u>, the effect of temperature (<a href="https://doi.org/10.1101/2020.04.14.20062463"><u><strong>https://doi.org/10.1101/2020.04.14.20062463</strong></u></a><u><strong>) </strong></u>and viral shedding / infectiousness (<a href="https://doi.org/10.1038/s41591-020-0869-5"><u><strong>https://doi.org/10.1038/s41591-020-0869-5</strong></u></a><u><strong>)</strong></u>.</p>
